Zobrazeno 1 - 10
of 428
pro vyhledávání: ''
Autor:
Charles D. Deakin, Simon M. Jepsen, Nete Hornung, Kasper Adelborg, Bo Løfgren, Leif F. Bach, Anders S Schmidt, Hans Rickers, Kasper G Lauridsen
Publikováno v:
Glerup Lauridsen, K, Schmidt, A S, Adelborg, K, Bach, L F, Hornung, N, Jepsen, S M, Deakin, C D, Rickers, H J V H & Løfgren, B 2018, ' Effects of hyperoxia on myocardial injury following cardioversion-A randomized clinical trial ', American Heart Journal, vol. 196, pp. 97-104 . https://doi.org/10.1016/j.ahj.2017.10.006
Background Oxygen has long been assumed beneficial for all ill and injured patients. However, hyperoxia may be harmful and aggravate myocardial injury such as that caused by myocardial infarction. We aimed to investigate if hyperoxia increases myocar
Autor:
Merri Swartz, Shaun G. Goodman, Matthias Heringlake, John H. Alexander, Wolfgang Toller, Sandra Tourt-Uhlig, James M. Meza, Sean van Diepen, Rajendra H. Mehta, John Luber, Jodi Parrotta, Paula M. Bokesch, Jerrold H. Levy, Robert A. Harrington, Douglas Hay, Kevin J. Anstrom, Rachael Jankowich, Stephen E. Fremes, Robert W. Harrison, Jeffrey D. Leimberger
Publikováno v:
American Heart Journal. 182:62-71
Background Low cardiac output syndrome is associated with increased mortality and occurs in 3% to 14% of patients undergoing cardiac surgery on cardiopulmonary bypass (CPB). Levosimendan, a novel calcium sensitizer and K ATP channel activator with in
Autor:
Masaya Sugimoto, Clara Kurishima, Hirotaka Ishido, Satoshi Masutani, Yoichi Iwamoto, Hirofumi Saiki, Hideaki Senzaki, Seiko Kuwata
Publikováno v:
American Heart Journal. 172:152-159
Background The mechanisms that regulate cerebral flow in patients after surgery for congenital heart diseases (CHDs) remain poorly understood. We tested our hypothesis that postoperative patients with CHD have disease- or hemodynamic-specific compens
Autor:
Marc S. Sabatine, Eric J. Topol, Christopher P. Cannon, Shamir R. Mehta, Keith A.A. Fox, Steven R. Steinhubl, Hussam Hamdalla
Publikováno v:
American Heart Journal. 155:910-917
Background Clopidogrel pretreatment before percutaneous coronary intervention (PCI) has been shown to reduce the risk of death and ischemic complications after PCI. However, the need for clopidogrel pretreatment is debated in patients receiving a gly
Autor:
Samir Saba, Evan Adelstein
Publikováno v:
American Heart Journal. 155:94-99
In patients with cardiac resynchronization therapy (CRT) devices, right atrial (RA) pacing introduces a significant prolongation in interatrial conduction time, delaying left atrial mechanical systole and curtailing left ventricular filling. The resu
Autor:
Athanasios A. Prekates, Constantine N. Fakiolas, Nikolaos G. Patsourakos, Evdokia N. Adamopoulou, Stylianos M. Handanis, Christopher D. Olympios, Spyros K. Argyrakis, Stefanos G. Foussas, Stamatis S. Makrygiannis, Evangelos G. Pissimissis, Michael N. Zairis
Publikováno v:
American Heart Journal. 154:676-681
Decreased responsiveness to oral antiplatelet drug therapy has been associated with an adverse outcome after coronary stenting (CS), but more studies are needed. The purpose of the present study was to prospectively evaluate this issue.A total of 612
Autor:
Francesco Nordio, Christian T. Ruff, Alon Eisen, Robert P. Giugliano, Vivek R. Awasty, Harinder S. Gogia, Howard Rutman, Michele Mercuri, Eugene Braunwald, David A. Henderson, Elliott M. Antman
Publikováno v:
American heart journal. 172
Background Edoxaban is a specific anti-Xa inhibitor that, in comparison to warfarin, has been found to be noninferior for the prevention of stroke or systemic embolism (SSE) and to reduce bleeding significantly in patients with nonvalvular atrial fib
Publikováno v:
American Heart Journal. 152:876-881
Background Platelet glycoprotein IIb/IIIa inhibitors are administered during percutaneous coronary intervention as a bolus followed by infusion. The need for an infusion was established by the Evaluation of 7E3 for the Prevention of Ischemic Complica
Autor:
Charles R. Kerr, Richard L. Page, Edward L.C. Pritchett, Peter R. Kowey, Stuart J. Connolly, William E. Wilkinson
Publikováno v:
American Heart Journal. 151:1043-1049
Azimilide dihydrochloride (azimilide) is an investigational antiarrhythmic drug that has been tested in patients with a variety of arrhythmias. In patients with atrial fibrillation, it has shown excellent efficacy in some previous trials and minimal
Autor:
Merritt H. Raitt, Robert G. Zoble, Annabelle Santos Volgman, Gilles O'Hara, Farooq A. Padder, David Kerr, Lyne Charbonneau
Publikováno v:
American Heart Journal. 151:390-396
The early recurrence of atrial fibrillation (AF) after cardioversion and the need for frequent cardioversions to maintain sinus rhythm are important clinical features of AF management.We evaluated patients in the AFFIRM study whose qualifying episode